| CAT No: | CL-IGU-04 |
| CAS No: | 123663-49-0 |
| Mol.F: | C17H14N2O6S |
| Mol.Wt.: | 374.4 |
| Chemical Name: | N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide |
| Inventory Status: | Custom Synthesis |
This impurity is related to Iguratimod is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Iguratimod is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Iguratimod Molecular Formula: C17H14N2O6S
Molecular Weight: 374.4
Storage: Store in a cool, dry place.
| Product Name: | Iguratimod |
| CAS No: | 123663-49-0 |
| Mol.F.: | C17H14N2O6S |
| Mol.Wt.: | 374.4 |
Cat. No: CL-IGU-02
CAS No: 123663-50-3
Mol. F: C18H16N2O6S
Mol. Wt: 388.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-03
CAS No: 1179354-65-4
Mol. F: C18H16N2O6S
Mol. Wt: 388.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-NO-1
CAS No: NA
Mol. F: C17H13N3O7S
Mol. Wt: 403.37
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-05
CAS No: 149457-03-4
Mol. F: C16H16N2O6S
Mol. Wt: 364.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-06
CAS No: 149436-41-9
Mol. F: C16H18N2O5S : HCl
Mol. Wt: 350.4 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-07
CAS No: 149456-98-4
Mol. F: C17H18N2O6S
Mol. Wt: 378.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-08
CAS No: 123662-92-0
Mol. F: C18H16N2O6S
Mol. Wt: 388.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-09
CAS No: 123663-48-9
Mol. F: C16H14N2O5S
Mol. Wt: 346.4
Inv. Status: Custom Synthesis
Cat. No: CL-IGU-10
CAS No: NA
Mol. F: C20H22N2O5S
Mol. Wt: 402.5
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: